Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Calcitriol and Naproxen in Recurrent Prostate Cancer
NCT00383487Phase 2Terminated
- Sponsor
- Stanford University
- Start
- Mar 2005
- Primary completion
- Jul 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of naproxen in prostate cancer (PCa), sponsored by Stanford University. Primary endpoint: PSA response. Started Mar 2005; status: terminated.
02
Drugs
naproxen
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00383487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00383487.